RE:RE:RE:RE:Novak ...porksniffer wrote: This turd is still churning on volume. Shareholders dumping with every bounce. Big holders want out. Mr. Bugs still thinks the 'old' JRG believers are still here. Big instutions are long gone, replaced by others who then also dump when they realize this is going nowhere. I got a good chuckle at #27 fastest growing company. Nearly 1 billion spent 'buying' growth in third world nations is not hard to do. Cash is running low. Organic growth here is pretty much nil and market knows this.
Unfortunately every word is "opinion without a trace or reality" but it's fun to see you guess wrong.
- those testing the waters and have been trying it over the past few years are the ones in/out. They are providing the downward pressure but that's expected for a while
- no evidence of big holders wanting out ... as big holders are the ones involved in annual AGM voting and the company shows the voting consistency there every year
- I don't know which big institutions are in and which are out ... but that isn't important to growth ... it's the strategy from within.
- they are 27 due to pure revenue growth from Grupo Biotoscana's purchase (that means nothing) but based on scoring, that's where they ranked. It just reminds investors we're going from 0 to 60 right now ... foundation has been built and operating revenue is flowing.
- if putting together the only LATAM and Canada reaching pharma at 6% of the world's pharma market isn't hard to do, why haven't you done it ? Cuz you can't ... and neither could Endo. Hahaha !
- bet you they know exactly where cash is coming from - finance whiz kids.
- they aren't much of an organic growth business as you perceive it ... but they have a lot of drugs still to come to market ... list is out there ! More to be added over time - like they did it before.
Nice try though. Back to the drawing board for you !!!!